Use of lactobacillus johnsonii GKJ2 for manufacturing lactobacillus composition for alleviating atopic dermatitis and regulating th2 and th17 cell immunity

TW202629228APending Publication Date: 2026-07-16GRAPE KING BIO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
GRAPE KING BIO LTD
Filing Date
2025-01-08
Publication Date
2026-07-16

Smart Images

  • Figure TWG2TA001067889_001
    Figure TWG2TA001067889_001
  • Figure TWG2TA001067889_002
    Figure TWG2TA001067889_002
  • Figure TWG2TA001067889_003
    Figure TWG2TA001067889_003
Patent Text Reader

Abstract

The present invention relates to a complex Lactobacilluscomposition for alleviating atopic dermatitis. The complex Lactobacilluscomposition includes at least one of Lactobacillus johnsoniiGKJ2 and L. plantarumGKK1. The complex Lactobacilluscomposition can be administered to a healthy subject in a continuation period, for significantly regulating Th1, Th2, Treg and Th17 cell immunity, altering gut microbiota, increasing the concentration of short-chain fatty acids in guts, thereby alleviating atopic dermatitis. Therefore, the complex Lactobacilluscomposition can be as an active ingredient for use in preparation of various compositions for alleviating atopic dermatitis.
Need to check novelty before this filing date? Find Prior Art